The Retinal Medicine Clinical Research Award is an annual initiative sponsored by EURETINA to support and encourage independent clinical research in the field of retinal medicine.
Clinician or non-clinician researchers, in a hospital or laboratory-based setting may conduct several types of clinical research, such as observational research studies, register studies (patient or disease registry), natural history / epidemiological studies, phase IV studies (post-authorisation safety studies, “PASS”), genomic research studies, pharmacovigilance studies, retrospective case-control studies, systematic reviews, meta-analyses and several other types of clinical studies.
The maximum budget that can be requested is €300,000 for up to two years. Appropriate justification is essential.
The competition is open to all clinicians and researchers, who’s current EURETINA membership commenced no later than March 2020, and who hold a full time clinical/research post at an EU-based clinical or academic research institute including H2020 associated countries and the UK. Principal applicants and collaborators from industry are ineligible to apply.
The Purpose of the Award is:
- To support, encourage and fund individuals that actively conduct clinical research in the field of retinal medicine.
- To facilitate and support an independent culture of clinical study for the ultimate benefit of patients with retinal disease.
- To engage and encourage the networking potential of the ophthalmic clinical community across the EU (and H2020 associated countries and the UK) to improve both patient care and outcomes.
Funding may be available over 2 years (maximum duration) for the right project with suitable infrastructure and experience.
Schedule
Deadline for Expression of Interest: Monday 1st February 2021, 18.00 CET
More information on: https://www.euretina.org/retinal-medicine/